• 4: Episode IV: Mike Zack, PGxAI

  • Oct 25 2024
  • Length: 46 mins
  • Podcast

4: Episode IV: Mike Zack, PGxAI

Listen for free

View show details

  • Summary

  • In their fourth epizode, Venture Vitals’ Tomas Studenik and Evgeny Shvarov invited a precision medicine startup CEO, Mike, to be their guest and respondent for over 45 minutes of all-about-building-a-global-med-tech-unicorn. Mike Zack, MD, PhD, MPH, is the Co-Founder and CEO of PGxAI (https://pgx.ai), a key opinion leader (KOL) in pharmacogenomics with an H-index of 40 and >40K citations. Mike is a member of major pharmacogenomics consortiums, including CPIC and PGRN, and has published in top-tier journals such as Nature Pharmacogenomics Journal, The Lancet, and others. Mike is supported by his co-founder and investor Allan Gobbs, who has successfully exited nine companies, and Russ Altman, a Stanford professor, serial entrepreneur, and world-leading KOL in multi-omics.

    PGX.ai is a Caelestinus Health Tech Incubator alumnus.
    Show More Show Less
Show More Show Less

What listeners say about 4: Episode IV: Mike Zack, PGxAI

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.